Who is sponsoring NCT00565240?

NCT00565240 is sponsored by University of Saskatchewan.

What condition does NCT00565240 study?

NCT00565240 studies Ovarian Follicle.

What drugs are being tested in NCT00565240?

Interventions: Marvelon, Nuvaring, Letrozole.

What is the status of NCT00565240?

NCT00565240 is currently COMPLETED.

Last reviewed 2010-04-20 · How we verify

Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women Protocol: WHIRL-07-2971

NCT00565240 NA COMPLETED

We hypothesize that administration of an aromatase inhibitor (AI) and hormonal contraceptives (HC) in the mid-luteal phase of the menstrual cycle will result in atresia of the follicles in the extant wave and cause synchronous re-emergence of a new follicular wave. We anticipate that this will provide us with information to facilitate the development of a new method for ovarian synchronization; a safer, more effective ovulation induction therapy; a new method for emergency contraception; and a greater understanding of human folliculogenesis.

Details

Lead sponsor	University of Saskatchewan
Phase	NA
Status	COMPLETED
Enrolment	41
Start date	2007-11
Completion	2009-09

Conditions

Ovarian Follicle

Interventions

Marvelon
Nuvaring
Letrozole

Primary outcomes

To evaluate differences in the mechanisms of atresia, initiation of a new synchronous follicular wave, interval to follicle wave emergence, interval to emergence of dominant follicle, interval to menstruation, and endometrial thickness/pattern. — 24-28 days

Countries

Canada